Exelixis
EXEL • NASDAQ • Stock Fundamentals
Exelixis is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Morrissey, with a market cap of $13.4B.
Market Cap$13.4B
Employees1.3K
CEOMichael Morrissey
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2027
View reportNext EarningsAug 4, 2026 · in 2 monthsAfter Market Close · Q2 2027
Financials
Based on Q1 2027 filing
Exelixis FAQ
Common questions about Exelixis
Exelixis (EXEL) has a market capitalization of $13.4B and trades on NASDAQ.
Exelixis has approximately 1,310 employees.